NLRP3 and metabolic dysfunction-associated steatotic liver disease: Researches have begun to recognize that TXNIP/NLRP3 activation is involved in the pathogenesis of type 1 diabetes- or fructose-associated NAFLD and that some phenolic compounds may confer protective effects by targeting TXNIP/NLRP3 pathway8, 19.